Capital Increase / Dilution2026-04-27
NGeneBio Co., Ltd. Paid-in Capital Increase
엔젠바
엔젠바이오
354200
Signal Score
59C — Neutral
Score59 / 100
Historical Avg Return (5d)
+1.59%
Data Coverage
100%n=1435
Risk-adjusted indicator based on 1435 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEGATIVE
Key Numbers
- • Issuance Price: To be determined (expected to be around 60% of the weighted average stock price)
- • Number of Shares: Not specified
3 more figures — unlock with API access
AI Analysis Summary
Developer & Pro plans
Risk Factors
Developer & Pro plans
Access Full Korean Market Signal Analytics
✔ AI-parsed DART filing classification & scoring
✔ Real-time event impact indicators
✔ Historical pattern data via REST API
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.
AI-processed analysis. Based on: 주요사항보고서(유상증자결정). Source: Financial Supervisory Service (금융감독원 전자공시시스템). Raw government data is not redistributed. Not investment advice.